CoChat
Sign Up
Cited by 722

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake

Kimiz-Gebologlu, Ilgin, Oncel, Suphi S.·2022·Journal of Controlled Release
DOI 10.1016/j.jconrel.2022.05.027
Open this paper in CoChat — free account

Abstract

Exosomes are nanovesicles with different contents that play a role in various biological and pathological processes. It offers significant advantages over other delivery systems such as liposomes and polymeric nanoparticles. Although exosomes are expected to be effective therapeutic agents, their optimal use remains a challenge. The development of methods for large-scale production, isolation, and drug loading is necessary to improve their efficiency and therapeutic potential. In this review, after mentioning general properties and biological functions of the exosomes, details of their potential for use in the drug delivery system are presented. For this purpose, methodologies for the large-scale production of exosomes, exosome isolation, exosomal cargo loading, and exosome uptake by the recipient cell are reviewed. The current challenges and potential directions of this new area of drug delivery that has become popular recently are also investigated.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2022.05.027

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 76

  1. Colombo, 2014, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, Annu. Rev. Cell Dev. Biol., 10.1146/annurev-cellbio-101512-122326 · DOI · Paper page
  2. Natasha, 2014, Exosomes as immunotheranostic nanoparticles, Clin. Ther., 36, 820, 10.1016/j.clinthera.2014.04.019 · DOI
  3. Anderson, 2016, Exosomes in viral disease, Neurotherapeutics, 10.1007/s13311-016-0450-6 · DOI
  4. Ferguson, 2016, Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity, J. Control. Release, 228, 179, 10.1016/j.jconrel.2016.02.037 · DOI
  5. Herrmann, 2021, Extracellular vesicles as a next-generation drug delivery platform, Nat. Nanotechnol., 16, 748, 10.1038/s41565-021-00931-2 · DOI · Paper page
  6. Chen, 2018, Pathways of production and delivery of hepatocyte exosomes, J. Cell Commun. Signal., 10.1007/s12079-017-0421-7 · DOI
  7. Gurung, 2021, The exosome journey: from biogenesis to uptake and intracellular signalling, Cell Commun. Signal., 19, 1, 10.1186/s12964-021-00730-1 · DOI
  8. Keerthikumar, 2016, ExoCarta: a web-based compendium of exosomal cargo, J. Mol. Biol., 428, 688, 10.1016/j.jmb.2015.09.019 · DOI
  9. Ortega, 2021, Exosomes as drug delivery systems: endogenous nanovehicles for treatment of systemic lupus erythematosus, Pharmaceutics, 13, 1
  10. Hamzah, 2021, Exosome traceability and cell source dependence on composition and cell-cell cross talk, Int. J. Mol. Sci., 22, 10.3390/ijms22105346 · DOI
  11. Jafari, 2020, Designer exosomes: a new platform for biotechnology therapeutics, BioDrugs, 34, 567, 10.1007/s40259-020-00434-x · DOI
  12. Gurunathan, 2019, Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes, Cells, 8, 307, 10.3390/cells8040307 · DOI
  13. Gimona, 2017, Manufacturing of human extracellular vesicle-based therapeutics for clinical use, Int. J. Mol. Sci., 10.3390/ijms18061190 · DOI
  14. Yousef, 2019, Exosomes: biological couriers with transformative messages, J. Biomed., 10.7150/jbm.34611 · DOI
  15. Kalluri, 2020, The biology, function, and biomedical applications of exosomes, Science (80-.), 6977
  16. Susa, 2019, Engineered extracellular vesicles as a reliable tool in cancer nanomedicine, Cancers (Basel), 11, 10.3390/cancers11121979 · DOI
  17. Lener, 2015, Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper, J. Extracell. Vesicles., 10.3402/jev.v4.30087 · DOI · Paper page
  18. Si, 2020, Targeted exosomes for drug delivery: biomanufacturing, surface tagging, and validation, Biotechnol. J., 15, 1, 10.1002/biot.201900163 · DOI
  19. Armstrong, 2018, Strategic design of extracellular vesicle drug delivery systems, Adv. Drug Deliv. Rev., 12, 10.1016/j.addr.2018.06.017 · DOI · Paper page
  20. Jesus, 2018, Exosomes as adjuvants for the recombinant hepatitis B antigen: first report, Eur. J. Pharm. Biopharm., 133, 1, 10.1016/j.ejpb.2018.09.029 · DOI
  21. Burke, 2016, Stem cell-derived exosomes: a potential alternative therapeutic agent in orthopaedics, Stem Cells Int., 10.1155/2016/5802529 · DOI
  22. Gingras, 2017, Exosome targeted therapy—a step in the future, Transl, Cancer Res., 6, S1398
  23. De Toro, 2015, Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications, Front. Immunol., 6, 10.3389/fimmu.2015.00203 · DOI
  24. Devhare, 2017, A novel role of exosomes in the vaccination approach, Ann. Transl. Med., 5, 3, 10.21037/atm.2016.12.75 · DOI
  25. Kim, 2018, Exosomes secreted from induced pluripotent stem cell-derived mesenchymal stem cells accelerate skin cell proliferation, Int. J. Mol. Sci., 19, 10.3390/ijms19103119 · DOI
  26. Colao, 2018, Manufacturing exosomes: a promising therapeutic platform, Trends Mol. Med., 24, 242, 10.1016/j.molmed.2018.01.006 · DOI · Paper page
  27. Yamashita, 2018, Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application, Biol. Pharm. Bull., 41, 835, 10.1248/bpb.b18-00133 · DOI
  28. Cheng, 2019, Recent advances in biosensors for detecting cancer-derived exosomes, Trends Biotechnol., 37, 1236, 10.1016/j.tibtech.2019.04.008 · DOI
  29. Kahlert, 2014, Exosomes in tumor microenvironment influence cancer progression and metastasis, J. Mol. Med., 91, 431, 10.1007/s00109-013-1020-6 · DOI
  30. Guo, 2017, Exosome: an emerging participant in the development of liver disease, Hepat. Mon., 10.5812/hepatmon.58021 · DOI
  31. Wang, 2017, Exosomes: a novel strategy for treatment and prevention of diseases, Front. Pharmacol., 8, 1
  32. Mirza, 2014, Nanomedicine and drug delivery: a mini review, Int. Nano Lett., 4, 10.1007/s40089-014-0094-7 · DOI
  33. Burgio, 2020, Extracellular vesicles-based drug delivery systems: a new challenge and the exemplum of malignant pleural mesothelioma, Int. J. Mol. Sci., 21, 10.3390/ijms21155432 · DOI
  34. Patra, 2018, Nano based drug delivery systems: recent developments and future prospects, J. Nanobiotechnology, 16, 1, 10.1186/s12951-018-0392-8 · DOI
  35. Cheng, 2017, Focus on mesenchymal stem cell-derived exosomes: opportunities and challenges in cell-free therapy, Stem Cells Int., 10.1155/2017/6305295 · DOI
  36. Liao, 2019, Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy, Acta Biomater.
  37. Abhange, 2021, Small extracellular vesicles in cancer, Bioact. Mater., 6, 3705
  38. Liu, 2019, Design strategies and application progress of therapeutic exosomes, Theranostics, 9, 1015, 10.7150/thno.30853 · DOI
  39. Patil, 2020, Exosomes as drug delivery systems: a brief overview and progress update, Eur. J. Pharm. Biopharm., 154, 259, 10.1016/j.ejpb.2020.07.026 · DOI
  40. Sancho-Albero, 2020, Use of exosomes as vectors to carry advanced therapies, RSC Adv., 10, 23975, 10.1039/D0RA02414G · DOI
  41. van Niel, 2022, Challenges and directions in studying cell–cell communication by extracellular vesicles, Nat. Rev. Mol. Cell Biol., 10.1038/s41580-022-00460-3 · DOI · Paper page
  42. Yang, 2018, The advances and challenges in utilizing exosomes for delivering cancer therapeutics, Front. Pharmacol., 9, 10, 10.3389/fphar.2018.00735 · DOI · Paper page
  43. Akuma, 2019, Naturally occurring exosome vesicles as potential delivery vehicle for bioactive compounds, Front. Sustain. Food Syst., 3, 10.3389/fsufs.2019.00023 · DOI
  44. Matejovič, 2021, Comparison of separation methods for tissue-derived extracellular vesicles in the liver, heart, and skeletal muscle, FEBS Open Bio., 11, 482, 10.1002/2211-5463.13075 · DOI
  45. Chen, 2020, Exosomes in clinical trial and their production in compliance with good manufacturing practice, Tzu Chi Med. J., 32, 113, 10.4236/cm.2020.113007 · DOI
  46. Andriolo, 2018, Exosomes from human cardiac progenitor cells for therapeutic applications: development of a GMP-grade manufacturing method, Front. Physiol., 9, 1, 10.3389/fphys.2018.01169 · DOI
  47. Li, 2015, Serum-free culture alters the quantity and protein composition of neuroblastoma-derived extracellular vesicles, J. Extracell. Vesicles., 4, 1, 10.3402/jev.v4.26883 · DOI
  48. Yi, 2020, Advances in analysis of biodistribution of exosomes by molecular imaging, Int. J. Mol. Sci., 21, 10.3390/ijms21020665 · DOI
  49. de Almeida Fuzeta, 2020, Scalable production of human mesenchymal stromal cell-derived extracellular vesicles under serum-/Xeno-free conditions in a microcarrier-based bioreactor culture system, front, Cell Dev. Biol., 8
  50. Chen, 2022, Review on strategies and technologies for exosome isolation and purification, Front. Bioeng. Biotechnol., 9, 1, 10.3389/fbioe.2021.811971 · DOI · Paper page
  51. Phan, 2018, Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy, J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1522236 · DOI
  52. Mendt, 2018, Generation and testing of clinical-grade exosomes for pancreatic cancer, JCI Insight, 3, 10.1172/jci.insight.99263 · DOI
  53. Kuystermans, 2011, Bioreactor systems for producing antibody from mammalian cells, 25, 10.1007/978-94-007-1257-7_2 · DOI
  54. Kumar, 2015, Large scale industrialized cell expansion: producing the critical raw material for biofabrication processes, Biofabrication, 7, 10.1088/1758-5090/7/4/044103 · DOI
  55. Gardiner, 2016, Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey, J. Extracell. Vesicles, 10.3402/jev.v5.32945 · DOI
  56. Sidhom, 2020, A review of exosomal isolation methods: is size exclusion chromatography the best option?, Int. J. Mol. Sci., 21, 1, 10.3390/ijms21186466 · DOI
  57. Shirejini, 2022, The yin and Yang of exosome isolation methods: conventional practice, microfluidics, and commercial kits, Biotechnol. Adv., 54, 10.1016/j.biotechadv.2021.107814 · DOI
  58. Benedikter, 2017, Ultrafiltration combined with size exclusion chromatography efficiently isolates extracellular vesicles from cell culture media for compositional and functional studies, Sci. Rep., 7, 1, 10.1038/s41598-017-15717-7 · DOI
  59. Inamdar, 2017, Emerging applications of exosomes in cancer therapeutics and diagnostics, Bioeng. Transl. Med., 10.1002/btm2.10059 · DOI
  60. Liangsupree, 2021, Modern isolation and separation techniques for extracellular vesicles, J. Chromatogr. A, 1636, 10.1016/j.chroma.2020.461773 · DOI
  61. Li, 2017, Progress in exosome isolation techniques, Theranostics, 7, 789, 10.7150/thno.18133 · DOI
  62. Enderle, 2015, Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method, PLoS One, 10, 1, 10.1371/journal.pone.0136133 · DOI
  63. Yu, 2018, A comparison of traditional and novel methods for the separation of exosomes from human samples, Biomed. Res. Int., 2018, 10.1155/2018/3634563 · DOI
  64. Mol, 2017, Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation, Nanomed. Nanotechnol. Biol. Med., 13, 2061, 10.1016/j.nano.2017.03.011 · DOI
  65. Zhou, 2018, Recent advances in exosome-based cancer immunotherapy, J. Cancer Immunol. Ther., 10.35841/cancer-immunology.1.1.9-16 · DOI
  66. Neerukonda, 2019, Comparison of exosomes purified via ultracentrifugation (UC) and Total exosome isolation (TEI) reagent from the serum of Marek’s disease virus (MDV)-vaccinated and tumor-bearing chickens, J. Virol. Methods, 263, 1, 10.1016/j.jviromet.2018.10.004 · DOI
  67. Luan, 2017, Engineering exosomes as refined biological nanoplatforms for drug delivery, Acta Pharmacol. Sin., 10.1038/aps.2017.12 · DOI
  68. Xu, 2020, Recent advancements in the loading and modification of therapeutic exosomes, Front. Bioeng. Biotechnol., 8, 10.3389/fbioe.2020.586130 · DOI
  69. Baek, 2019, Mesenchymal stem cell-derived extracellular vesicles as therapeutics and as a drug delivery platform, Stem Cells Transl. Med., 8, 880, 10.1002/sctm.18-0226 · DOI
  70. Mehryab, 2020, Exosomes as a next-generation drug delivery system: an update on drug loading approaches, characterization, and clinical application challenges, Acta Biomater., 113, 42, 10.1016/j.actbio.2020.06.036 · DOI · Paper page
  71. Xi, 2021, Lu, drug loading techniques for exosome-based drug delivery systems, Pharmazie, 76, 61
  72. Kang, 2021, Biodistribution of extracellular vesicles following administration into animals: a systematic review, J. Extracell. Vesicles, 10, 10.1002/jev2.12085 · DOI
  73. Mathieu, 2019, Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication, Nat. Cell Biol., 21, 9, 10.1038/s41556-018-0250-9 · DOI
  74. Kwok, 2021, Extracellular vesicle transportation and uptake by recipient cells: a critical process to regulate human diseases, Processes, 9, 1, 10.3390/pr9020273 · DOI
  75. McKelvey, 2015, Exosomes: mechanisms of uptake, J. Circ. Biomarkers., 4, 1
  76. Carpintero-Fernández, 2017, Technical advances to study extracellular vesicles, Front. Mol. Biosci., 4, 1, 10.3389/fmolb.2017.00079 · DOI

Cited by

Sorted by citations

See all 722

Metadata

Authors
Kimiz-Gebologlu, I., & Oncel, S. S.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2022-07
Volume
347
Pages
533-543
ISSN
0168-3659
DOI
10.1016/j.jconrel.2022.05.027
Cited by
722
References
9
Language
en
Licence
Funders
  • Ege Üniversitesi (22868)
  • Horizon 2020 Framework Programme

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review